About Synergetics USA (NASDAQ:SURG)
Synergetics USA, Inc., formerly Valley Forge Scientific Corp., is a supplier of precision surgical devices. The Company focuses on the surgical disciplines of ophthalmology and neurosurgery. It offers precision engineered disposable and reusable devices, surgical equipment and surgical procedural kits. It also delivers energy modalities for the performance of surgery, including laser energy, ultrasonic energy, radio frequency energy for electro surgery and lesion generation, visible light energy for illumination and simultaneous infusion (irrigation) of fluids into the operative field. Its products include VersaVIT 2.0 Vitrectomy System, Directional II Laser Probe and Pinnacle 360�. It offers its products under the brand names: VersaPACK, Core Essentials, Photon, Solitaire, Volk's and Labtician's, among others. It offers approximately 1,000 separate catalogue items in the vitreoretinal surgical market. It sells its products in approximately 60 countries outside the United States.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNASDAQ:SURG
CUSIPN/A
WebN/A
Phone+1-636-9395100
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins7.35%
Return on Equity9.09%
Return on Assets6.45%
Miscellaneous
EmployeesN/A
Outstanding Shares25,630,000
Synergetics USA (NASDAQ:SURG) Frequently Asked Questions
What is Synergetics USA's stock symbol?
Synergetics USA trades on the NASDAQ under the ticker symbol "SURG."
How were Synergetics USA's earnings last quarter?
Synergetics USA Inc (NASDAQ:SURG) issued its earnings results on Wednesday, October, 14th. The medical equipment provider reported $0.06 EPS for the quarter, hitting analysts' consensus estimates of $0.06. Synergetics USA had a net margin of 7.35% and a return on equity of 9.09%. View Synergetics USA's Earnings History.
Has Synergetics USA been receiving favorable news coverage?
Media stories about SURG stock have trended somewhat positive on Monday, Accern reports. The research group identifies positive and negative press coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Synergetics USA earned a media sentiment score of 0.12 on Accern's scale. They also assigned media headlines about the medical equipment provider an impact score of 45.99 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near term.
How do I buy shares of Synergetics USA?
Shares of SURG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Synergetics USA's stock price today?
One share of SURG stock can currently be purchased for approximately $0.25.
How can I contact Synergetics USA?
Synergetics USA's mailing address is 3845 Corporate Centre Dr, O'FALLON, MO 63368-8678, United States. The medical equipment provider can be reached via phone at +1-636-9395100.
MarketBeat Community Rating for Synergetics USA (SURG)
MarketBeat's community ratings are surveys of what our community members think about Synergetics USA and other stocks. Vote "Outperform" if you believe SURG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SURG will underperform the S&P 500 over the long term. You may vote once every thirty days.
Synergetics USA (NASDAQ:SURG) Analyst Ratings History
| Date | Brokerage | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
(Data available from 4/23/2016 forward)
Synergetics USA (NASDAQ:SURG) Earnings History and Estimates Chart
Synergetics USA (NASDAQ SURG) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/14/2015 | Q4 | $0.06 | $0.06 | | | View | N/A |  |
| 6/9/2015 | Q315 | $0.04 | $0.05 | $19.16 million | $19.38 million | View | N/A | |
| 3/10/2015 | Q215 | $0.02 | $0.07 | $17.60 million | $18.20 million | View | N/A | |
| 12/10/2014 | Q115 | $0.02 | $0.03 | $15.76 million | $16.60 million | View | N/A | |
| 10/14/2014 | Q414 | $0.03 | $0.06 | $17.32 million | $18.00 million | View | Listen | |
| 6/9/2014 | Q314 | $0.04 | $0.04 | $16.50 million | $16.10 million | View | N/A | |
| 3/6/2014 | Q214 | $0.03 | $0.01 | $15.10 million | $15.10 million | View | N/A | |
| 12/9/2013 | Q1 | $0.04 | $0.04 | $15.73 million | $15.50 million | View | Listen | |
| 10/1/2013 | Q413 | $0.06 | $0.06 | $17.01 million | $17.90 million | View | N/A | |
| 6/10/2013 | Q3 2013 | $0.03 | $0.05 | $14.99 million | $16.30 million | View | N/A | |
| 3/12/2013 | Q2 2013 | $0.07 | $0.05 | $16.09 million | $14.06 million | View | N/A | |
| 12/10/2012 | 0.05 | $0.05 | $0.05 | $14.37 million | $14.60 million | View | N/A | |
| 10/1/2012 | Q412 | $0.08 | $0.08 | $16.61 million | $16.90 million | View | N/A | |
| 6/11/2012 | | $0.04 | $0.04 | | | View | N/A | |
| 3/12/2012 | | $0.07 | $0.07 | | | View | N/A | |
| 12/12/2011 | | $0.04 | $0.05 | | | View | N/A | |
| 10/11/2011 | | $0.07 | $0.08 | | | View | N/A | |
| 6/7/2011 | | $0.06 | $0.07 | | | View | N/A | |
| 3/9/2011 | Q2 2011 | $0.04 | $0.05 | | | View | N/A | |
| 12/14/2010 | Q1 2011 | $0.03 | $0.03 | | | View | N/A | |
| 10/12/2010 | Q4 2010 | | $0.04 | | | View | N/A | |
| 6/14/2010 | Q3 2010 | | $0.05 | | | View | N/A | |
| 3/17/2010 | Q2 2010 | | $0.04 | | | View | N/A | |
| 12/15/2009 | Q1 2010 | | $0.02 | | | View | N/A | |
| 6/15/2009 | Q3 2009 | | $0.02 | | | View | N/A | |
| 3/16/2009 | Q2 2009 | | $0.02 | | | View | N/A | |
| 12/8/2008 | Q1 2009 | | $0.03 | | | View | N/A | |
| 10/14/2008 | Q4 2008 | | $0.05 | | | View | N/A | |
| 6/9/2008 | Q3 2008 | | $0.05 | | | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
Synergetics USA (NASDAQ:SURG) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Synergetics USA (NASDAQ SURG) Insider Trading and Institutional Ownership History
Synergetics USA (NASDAQ SURG) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 12/31/2014 | Michael Fanning | VP | Sell | 5,000 | $4.32 | $21,600.00 | | |
| 10/20/2014 | David Graeme Thomas | Director | Buy | 1,000 | $3.37 | $3,370.00 | | |
| 3/26/2014 | David Hable | CEO | Buy | 3,257 | $3.04 | $9,901.28 | 110,195 | |
| 3/21/2014 | David Graeme Thomas | Director | Buy | 1,000 | $3.07 | $3,070.00 | 2,000 | |
| 1/3/2014 | Michael Fanning | VP | Sell | 2,290 | $3.47 | $7,946.30 | 76,978 | |
| 10/16/2013 | Jerry L Malis | EVP | Sell | 10,000 | $4.57 | $45,700.00 | | |
| 10/15/2013 | Jerry Malis | EVP | Sell | 40,000 | $4.55 | $182,000.00 | 354,200 | |
| 10/11/2013 | Michael Fanning | VP | Sell | 4,000 | $4.67 | $18,680.00 | 79,268 | |
| 10/10/2013 | Jerry Malis | EVP | Sell | 50,605 | $4.60 | $232,783.00 | 394,200 | |
| 10/7/2013 | Jerry Malis | EVP | Sell | 49,395 | $4.50 | $222,277.50 | 444,805 | |
| 3/20/2013 | Michael Fanning | VP | Buy | 2,000 | $3.43 | $6,860.00 | | |
| 3/19/2013 | Michael Fanning | VP | Buy | 7,300 | $3.30 | $24,090.00 | | |
(Data available from 1/1/2013 forward)
Synergetics USA (NASDAQ SURG) News Headlines
| Source: |
|
Synergetics USA (NASDAQ:SURG) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Synergetics USA (NASDAQ:SURG) Income Statement, Balance Sheet and Cash Flow Statement
Synergetics USA (NASDAQ SURG) Stock Chart for Monday, April, 23, 2018
Loading chart…
